PROTO LABS INC (PRLB)

US7437131094 - Common Stock

39.74  +0.49 (+1.25%)

After market: 39.74 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRLB. PRLB was compared to 131 industry peers in the Machinery industry. PRLB has an excellent financial health rating, but there are some minor concerns on its profitability. PRLB is valied quite expensively at the moment, while it does show a decent growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year PRLB was profitable.
PRLB had a positive operating cash flow in the past year.
Of the past 5 years PRLB 4 years were profitable.
PRLB had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of PRLB (3.18%) is comparable to the rest of the industry.
PRLB's Return On Equity of 3.53% is in line compared to the rest of the industry. PRLB outperforms 40.16% of its industry peers.
The Return On Invested Capital of PRLB (2.63%) is worse than 69.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 11.01%.
The last Return On Invested Capital (2.63%) for PRLB is above the 3 year average (2.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.18%
ROE 3.53%
ROIC 2.63%
ROA(3y)-2.36%
ROA(5y)1.84%
ROE(3y)-2.78%
ROE(5y)2.09%
ROIC(3y)2.51%
ROIC(5y)4.14%

1.3 Margins

PRLB has a Profit Margin (4.76%) which is in line with its industry peers.
In the last couple of years the Profit Margin of PRLB has declined.
With a Operating Margin value of 5.92%, PRLB perfoms like the industry average, outperforming 43.31% of the companies in the same industry.
PRLB's Operating Margin has declined in the last couple of years.
PRLB has a better Gross Margin (45.03%) than 87.40% of its industry peers.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 5.92%
PM (TTM) 4.76%
GM 45.03%
OM growth 3Y-25.76%
OM growth 5Y-22.35%
PM growth 3Y-33.68%
PM growth 5Y-27.61%
GM growth 3Y-4.22%
GM growth 5Y-3.83%

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
Compared to 1 year ago, PRLB has less shares outstanding
Compared to 5 years ago, PRLB has less shares outstanding
PRLB has a better debt/assets ratio than last year.

2.2 Solvency

PRLB has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
PRLB has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. PRLB outperforms 93.70% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
PRLB has a better Debt to Equity ratio (0.00) than 82.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC0.29
WACC9.2%

2.3 Liquidity

A Current Ratio of 3.59 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a better Current ratio (3.59) than 84.25% of its industry peers.
PRLB has a Quick Ratio of 3.36. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.36, PRLB belongs to the top of the industry, outperforming 90.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 3.36

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.14% over the past year.
The earnings per share for PRLB have been decreasing by -12.05% on average. This is quite bad
Looking at the last year, PRLB shows a small growth in Revenue. The Revenue has grown by 1.96% in the last year.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 2.49% on average per year.
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y-12.05%
EPS Q2Q%-7.84%
Revenue 1Y (TTM)1.96%
Revenue growth 3Y5.07%
Revenue growth 5Y2.49%
Sales Q2Q%-3.89%

3.2 Future

The Earnings Per Share is expected to decrease by -3.19% on average over the next years.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.18% yearly.
EPS Next Y-1.83%
EPS Next 2Y-3.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.64%
Revenue Next 2Y1.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

PRLB is valuated rather expensively with a Price/Earnings ratio of 23.24.
PRLB's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.96, PRLB is valued at the same level.
PRLB is valuated quite expensively with a Price/Forward Earnings ratio of 26.50.
The rest of the industry has a similar Price/Forward Earnings ratio as PRLB.
PRLB's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 23.24
Fwd PE 26.5

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PRLB is cheaper than 62.20% of the companies in the same industry.
PRLB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PRLB is cheaper than 77.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19
EV/EBITDA 12.84

4.3 Compensation for Growth

PRLB's earnings are expected to decrease with -3.19% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.19%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (11/21/2024, 8:04:00 PM)

After market: 39.74 0 (0%)

39.74

+0.49 (+1.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap974.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 23.24
Fwd PE 26.5
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.18%
ROE 3.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.92%
PM (TTM) 4.76%
GM 45.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.59
Quick Ratio 3.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)22.14%
EPS 3Y-12.27%
EPS 5Y
EPS Q2Q%
EPS Next Y-1.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.96%
Revenue growth 3Y5.07%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y